Phathom Pharmaceuticals Addresses Litigation Filed by BDR Pharmaceuticals Against FDA

Article summary

Phathom Pharmaceuticals announced that BDR Pharmaceuticals has filed a lawsuit against the FDA challenging the agency's refusal to accept an ANDA referencing Phathom's VOQUEZNA, specifically contesting the extension of Phathom's NCE exclusivity.